Results from HELIOS-A RTE Period Presented during Annual Meeting of the ASNP

Results from HELIOS-A RTE Period Presented during Annual Meeting of the ASNP

Nine month results from the randomized treatment extension (RTE) period of the HELIOS-A study of vutrisiran in patients with the polyneuropathy of hereditary ATTR amyloidosis were presented at the Italian Association for the Study of the Peripheral Nervous System.

Obici, et al. “HELIOS-A: 9-Month Results from the Randomized Treatment Extension Period of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy”